Inhalation of Motor Vehicle Emissions can Clog Arteries
Submitted by Dinesh Chandra Gaur on Sat, 05/18/2013 - 12:38
Breathing motor vehicle emissions is not good for health, reveals a study published in the journal Arteriosclerosis, Thrombosis and Vascular Biology.
The study, which has been carried out by group of researchers from different institutions, has revealed that inhaling of motor vehicle emissions brings change in high-density lipoprotein (HDL) cholesterol.
Simvastatin Cuts Positive Effects of Exercise for Obese Adults: Researchers
Submitted by Pallavi Sharma on Sat, 05/18/2013 - 09:28
Statins are widely recommended by medical experts to bring down levels of cholesterol and prevent heart disease in individuals with obesity, diabetes and metabolic syndrome.
Game to Support Reconciliation in Community
Submitted by Neeraj Shahane on Sat, 05/18/2013 - 09:18
The expanded version of AFL Cairns' Dreamtime by the Sea was a winner last year. Organizers said it will certainly support and raise awareness for reconciliation in the community. The event features sport, but it is much more than a game of football.
Pending Calls for Ambulance Lead to Death of a Man after Drinking a Dose of Disinfectant
Submitted by Dinesh Chandra Gaur on Sat, 05/18/2013 - 09:11
An inquest heard that up to 50 calls were pending to respond for ambulances, which led to the death of a man who drank a fatal dose of disinfectant. The man first rang 000 for help, but died because no ambulance was available to provide him much needed care.
Increase in Number of Unpaid and Young Carers
Submitted by Pallavi Sharma on Sat, 05/18/2013 - 08:31
The Guardian said children are performing the role of carers that the state has abandoned while the Independent said nearly 180,000 children are working as unpaid carers. The new figures have been revealed by the Office for National Statistics.
New Cancer Drug Compounds Moved Forward to Phase-III Development
Submitted by Neeraj Shahane on Sat, 05/18/2013 - 08:21
As per reports, three compounds of the new cancer drug by the AstraZeneca have been moved forward for the phase-III clinical development.
